Should the ertapenem‑meropenem regimen be continued if the patient is only colonized with a resistant organism?

Do Not Continue Ertapenem-Meropenem for Colonization Alone

Routine antibiotic treatment must not be prescribed if a bacterium is identified when determining colonization status, and treating microbial colonizations is not recommended 1, 2. The ertapenem-meropenem regimen should be discontinued if the patient is only colonized with a resistant organism and has no signs of active infection.

Key Distinction: Colonization vs. Infection

The critical first step is determining whether the patient has true infection versus colonization 3:

• Colonization = organism present without clinical signs of infection (no fever, no elevated inflammatory markers, no organ dysfunction attributable to infection)
• Active infection = organism present WITH clinical manifestations requiring treatment

Nearly half of patients with carbapenem-resistant organisms represent colonization, yet the majority are inappropriately treated with broad-spectrum antibiotics 3. This over-treatment increases antimicrobial resistance risk without clinical benefit.

Evidence-Based Approach

When to STOP the Regimen (Colonization):

The 2015 ICU guidelines explicitly state that routine antibiotic treatment must not be prescribed based solely on colonization status, particularly from endotracheal aspirates or surveillance cultures 1. The risk of not treating apparent colonization is low - only 1 patient out of multiple colonized cases subsequently developed infection 29 days later 3.

When to CONTINUE (Active Infection):

The regimen should only continue if:

• Signs of severe infection are present (fever, hemodynamic instability, organ dysfunction)
• The patient has multidrug-resistant bacteria AND severe sepsis/septic shock 1
• Clinical deterioration despite source control measures

Infection Control Considerations

If colonized with carbapenem-resistant organisms:

• Maintain contact precautions 4, 5
• Place in private room or cohort with other colonized patients 5
• Use dedicated equipment 5
• Continue surveillance but do not treat colonization 6

Common Pitfall to Avoid

Do not confuse positive cultures with need for treatment. The presence of resistant organisms on culture does not automatically warrant carbapenem therapy 1, 3. Prescribing ertapenem in the absence of proven bacterial infection increases the risk of drug-resistant bacteria development 7.

Clinical Decision Algorithm:

1. Assess for infection signs: fever, leukocytosis, hemodynamic instability, organ dysfunction
2. If absent → STOP antibiotics, maintain infection control precautions
3. If present → Continue treatment, adjust based on susceptibilities
4. Monitor closely for 48-72 hours after stopping - development of infection from colonization is rare 3

The 2019 ESCMID guidelines on decolonization of multidrug-resistant gram-negative bacteria explicitly recommend against routine decolonization of carbapenem-resistant Enterobacteriaceae carriers 6, reinforcing that colonization alone does not warrant antimicrobial therapy.